SFA Therapeutics logo

SFA Therapeutics

Regulating the immune system to block cancer & autoimmune diseases

Philadelphia, US

AI-powered Drug DiscoveryAnti-AgingBiotechHealth & WellnessBiotechnology
SFA Therapeutics is creating therapeutically-tailored oral drugs that regulate the immune system; with a focus on autoimmune diseases and cancers that originate from chronic inflammation. There are over 300 million patients who suffer from autoimmune diseases. Our treatment is designed to block the root cause of many of these chronic inflammatory diseases, with safe oral drugs. We have strong clinical data from a phase 1b clinical trial in psoriasis, and human data in pancreatic cancer, uveitis and NASH. we have a total of 9 drugs in our pipeline and 15 patents.
Meet the team3

The people behind SFA Therapeutics

Ira Spector
Ira Spector
Founder
LinkedIn profile
Alla Arzumanyan
Alla Arzumanyan
Founder
LinkedIn profile
Mark Feitelson
Mark Feitelson
Founder
LinkedIn profile